ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

FFP Consolidated Firstfund Capital Corp

0.20
0.00 (0.00%)
20 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Consolidated Firstfund Capital Corp TSXV:FFP TSX Venture Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.20 0.15 0.25 0 01:00:00

Firstfund Reports 2017 Fourth Quarter Results

01/05/2018 1:39am

PR Newswire (Canada)


Consolidated Firstfund C... (TSXV:FFP)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Consolidated Firstfund C... Charts.

Trading Symbol: FFP

VANCOUVER, April 30, 2018 /CNW/ - The financial results of Consolidated Firstfund Capital Corp. for the three months ended December 31, 2017 show a net income of $250,460 or $0.04 per share (2016 - net income of $73,286 or $0.01 per share) on revenues of $323,781 (2016 - $152,042). The Company recorded an unrealized gain of $245,302 (2016 - $70,087) on the revaluation of the investment in Vitality Products Inc. common shares measured at fair value through profit or loss. The Company's fee income decreased to $77,790 for the three months ended December 31, 2017 (2016 - $81,536).

The financial results of the Company for the year ended December 31, 2017 show a net income of $207,936 or $0.03 per share (2016 - $204,801 or $0.03 per share). The Company recorded an unrealized gain of $175,216 (2016 - $175,217) on the revaluation of the investment in Vitality Products Inc. common shares. The Company's fee income decreased to $317,520 for the year ended December 31, 2017 (2016 - $324,146).

The Company has retrospectively revised the account for the following two items causing the restatement of the 2016 comparatives. The first item is prior to 2017 the Company disclosed the aggregate amount of the cumulative dividends on its redeemable preference shares. In the current fiscal year, management determined the accounting treatment for these dividends should be to accrue the cumulative dividends on an annual basis because these shares are redeemable and are presented as a financial liability. The second item is management has determined the Company had significant influence over Vitality Products Inc. which should be restated retrospectively. As a venture capital company and pursuant to the exemptions in IAS 28 "Investments in Associates and Joint Ventures", management determined the accounting treatment for the Company's investment in Vitality Products Inc. common shares to be measured at fair value through profit or loss. This investment was previously classified as available-for-sale and measured at fair value through other comprehensive income. The summary of the effect of these changes is in Note 4 to the consolidated financial statements for the years ended December 31, 2017 and 2016.

The Company's audited consolidated financial statements and management's discussion and analysis for the years ended December 31, 2017 and 2016 are available on SEDAR at www.sedar.com.

On behalf of the Board of 
CONSOLIDATED FIRSTFUND CAPITAL CORP.

"W. Douglas Grant" (signed)
______________________________
W. Douglas Grant, President & CEO

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE Consolidated Firstfund Capital Corp.

Copyright 2018 Canada NewsWire

1 Year Consolidated Firstfund C... Chart

1 Year Consolidated Firstfund C... Chart

1 Month Consolidated Firstfund C... Chart

1 Month Consolidated Firstfund C... Chart